• Journal of the Korean Chemical Society
• /
• v.67 no.4
• /
• pp.226-235
• /
• 2023

Chikungunya fever has a high morbidity rate in humans and is caused by chikungunya virus. There are no treatments available until now for this particular viral disease. The present study was carried out by selecting 19 flavonoids, which are available naturally in fruits, vegetables, tea, red wine and medicinal plants. The molecular docking of selected 19 flavonoids was carried out against the Chikungunya virus capsid protein using the Autodock4.2 software. Binding affinity analysis based on the Intermolecular interactions such as Hydrogen bonding and hydrophobic interactions and drug-likeness properties for all the 19 flavonoids have been carried out and it is found that the top four molecules are Chrysin, Fisetin, Naringenin and Biochanin A as they fit to the chikungunya protein and have binding energy of -8.09, -8.01, -7.6, and 7.3 kcal/mol respectively. This result opens up the possibility of applying these compounds in the inhibition of chikungunya viral protein.

• Journal of Microbiology and Biotechnology
• /
• v.29 no.11
• /
• pp.1852-1859
• /
• 2019

Chikungunya virus (CHIKV) is a single-stranded positive-sense RNA virus, belonging to the genus Alphavirus of the Togaviridae family. It causes multiple symptoms, including headache, fever, severe joint and muscle pain, and arthralgia. Since CHIKV was first isolated in Tanzania in 1952, there have been multiple outbreaks of chikungunya fever. However, its pathogenesis and mechanisms of viral immune evasion have been poorly understood. In addition, the exact roles of individual CHIKV genes on the host innate immune response remain largely unknown. To investigate if CHIKV-encoded genes modulate the type I interferon (IFN) response, each and every CHIKV gene was screened for its effects on the induction of the IFN-β promoter. Here we report that CHIKV nsP2, E2 and E1 strongly suppressed activation of the IFN-β promoter induced by the MDA5/RIG-I receptor signaling pathway, suggesting that nsP2, E2, and E1 are the major antagonists against induction of IFN-β. Delineation of underlying mechanisms of CHIKV-mediated inhibition of the IFN-β pathway may help develop virus-specific therapeutics and vaccines.

• Journal of Microbiology and Biotechnology
• /
• v.31 no.12
• /
• pp.1716-1721
• /
• 2021

Chikungunya fever is an arboviral disease caused by the Chikungunya virus (CHIKV). The disease has similar clinical manifestations with other acute febrile illnesses which complicates differential diagnosis in low-resource settings. We aimed to develop a rapid test for CHIKV detection based on the nucleic acid lateral flow immunoassay technology. The system consists of a primer set that recognizes the E1 region of the CHIKV genome and test strips in an enclosed cassette which are used to detect amplicons labeled with FITC/biotin. Amplification of the viral genome was done using open-source PCR, a low-cost open-source thermal cycler. Assay performance was evaluated using a panel of RNA isolated from patients' blood with confirmed CHIKV (n = 8) and dengue virus (n = 20) infection. The open-source PCR-NALFIA platform had a limit of detection of 10 RNA copies/ml. The assay had a sensitivity and specificity of 100% (95% CI: 67.56% - 100%) and 100% (95% CI: 83.89% - 100%), respectively, compared to reference standards of any positive virus culture on C6/36 cell lines and/or qRT-PCR. Further evaluation of its performance using a larger sample size may provide important data to extend its usefulness, especially its utilization in the peripheral healthcare facilities with scarce resources and outbreak situations.

• Parasites, Hosts and Diseases
• /
• v.54 no.2
• /
• pp.239-241
• /
• 2016

Chikungunya virus (CHIKV), a tropical pathogen, has re-emerged and has massive outbreaks abruptly all over the world. Containing many dominant epitopes, the envelope E2 protein of CHIKV has been explored for the vaccination or diagnosis. In the present study, the antigenicity of a recombinant expressed intrinsically disorder domain (IUD) of E2 was tested for the detection of the antibody against CHIKV through western blot method. The gene of the IUD of E2 was inserted into 2 different vectors and expressed as recombinant GST-E2 and recombinant MBP-E2 fusion protein, respectively. Two kinds of fusion proteins were tested with 30 CHIKV patient sera and 30 normal sera, respectively. Both proteins were detected by 25 patients sera (83.3%) and 1 normal serum (3.3%). This test showed a relatively high sensitivity and very high specificity of the recombinant E2 proteins to be used as diagnostic antigens against CHIKV infection.

• Journal of Microbiology and Biotechnology
• /
• v.30 no.12
• /
• pp.1801-1809
• /
• 2020

Chikungunya virus (CHIKV) was first identified in 1952 as a causative agent of outbreaks. CHIKV is transmitted by two mosquito species, Aedes aegypti and A. albopictus. Symptoms after CHIKV infection in human are typically fever and joint pain, but can also include headache, muscle pain, joint swelling, polyarthralgia, and rash. CHIKV is an enveloped single-stranded, positive-sense RNA virus with a diameter of approximately 70 nm. The pathogenesis of CHIKV infection and the mechanism by which the virus evades the innate immune system remain poorly understood. Moreover, little is known about the roles of CHIKV-encoded genes in the viral evasion of host immune responses, especially type I interferon (IFN) responses. Therefore, in the present study, we screened CHIKV-encoded genes for their regulatory effect on the activation of nuclear factor kappa B (NF-κB), a critical transcription factor for the optimal activation of IFN-β. Among others, non-structural protein 2 (nsP2) strongly inhibited melanoma differentiation-associated protein 5 (MDA5)-mediated induction of the NF-κB pathway in a dose-dependent manner. Elucidation of the detailed mechanisms of nsP2-mediated inhibition of the MDA5/RIG-I signaling pathway is anticipated to contribute to the development of virus-specific therapeutics against CHIKV infection.

• Proceedings of the Korea Contents Association Conference
• /
• 2014.11a
• /
• pp.55-56
• /
• 2014

치쿤구니아열은 치쿤구니아 바이러스(chikungu- nya virus)에 감염된 매개 모기(열대숲모기 및 흰줄숲모기)에 물려 감염되는 급성 열성 질환으로 잠복기가 짧고 치료제가 없기 때문에 조기 진단이 매우 중요한 급성전염병이다. 아열대기후로 진입하는 우리나라에서도 흰줄숲모기가 자주 발견되기 때문에 이 질병으로부터 결코 자유롭지가 않다. 치쿤구니아 바이러스 감염을 진단하기 위한 진단키트를 개발하기 위해 먼저 타깃 유전자 부위 선정이 매우 중요하다. 본 연구에서는 생명정보학을 기반으로 이 바이러스 만을 검출할 수 있는 epitope를 예측하고자 한다. 이 바이러스의 capsid 유전자를 찾고 유사한 바이러스의 유전자들과 multiple alignment를 수행하여 이 바이러스만이 가지고 있는 독특한 부위를 추출하였다. 이후 ProtScale Tool 프로그램으로 선택한 단백질의 친수성(hydrophilicity), 접근성(accessi- bility), 유연성(flexibility), 회전(${\beta}$-turns) 등의 특성을 모두 만족하는 부위를 선별하여 진단키트 제작을 위한 epitope를 제시하고자 한다.

• Journal of Biosystems Engineering
• /
• v.42 no.3
• /
• pp.217-226
• /
• 2017

Purpose: Aedes aegypti and Aedes albopictus are notorious disease vectors that spread various viruses including dengue, yellow fever, chikungunya, and Zika. Recent Zika virus outbreaks were carried by Ae. aegypti, raising awareness about the perils of its global distribution. Because Ae. albopictus is spread throughout South Korea and can carry the same viruses as Ae. aegypti, monitoring potential distributions of Ae. albopictus and Ae. aegypti is necessary. Methods: In this study, the potential distributions of Ae. albopictus and Ae. aegypti in South Korea were modeled using CLIMEX software, and changes in response to climate change were predicted. Results: The results indicated that the climatic suitability for Ae. albopictus was consistently high, while occurrence of Ae. aegypti was only predicted for Jeju Island in 2080. Conclusions: The results provide basic information for preventing the invasion of Ae. aegypti, and consequent interactions between Ae. aegypti and Ae. albopictus, which may cause severe outbreaks of dangerous diseases.

• Parasites, Hosts and Diseases
• /
• v.57 no.3
• /
• pp.283-290
• /
• 2019

A rapid diagnostic test (RDT) kit was developed to detect non-structural protein 1 (NS1) of yellow fever virus (YFV) using monoclonal antibody. NS1 protein was purified from the cultured YFV and used to immunize mice. Monoclonal antibody to NS1 was selected and conjugated with colloidal gold to produce the YFV NS1 RDT kit. The YFV RDTs were evaluated for sensitivity and specificity using positive and negative samples of monkeys from Brazil and negative human blood samples from Korea. Among monoclonal antibodies, clones 3A11 and 3B7 proved most sensitive, and used for YFV RDT kit. Diagnostic accuracy of YFV RDT was fairly high; Sensitivity was 0.0% and specificity was 100% against Dengue viruses type 2 and 3, Zika, Chikungunya and Mayaro viruses. This YFV RDT kit could be employed as a test of choice for point-of-care diagnosis and large scale surveys of YFV infection under clinical or field conditions in endemic areas and on the globe.